Jyong Biotech Ltd. (MENS)
(Delayed Data from NSDQ)
$59.53 USD
-6.09 (-9.28%)
Updated Sep 22, 2025 04:00 PM ET
After-Market: $58.05 -1.48 (-2.49%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MENS 59.53 -6.09(-9.28%)
Will MENS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MENS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for MENS
12 Health Care Stocks Moving In Monday's Intraday Session
Crossed Above 20 Day Moving Average appears for MENS after 26.8% move
Fell Below 20 Day Moving Average appears for MENS after 3.65% move
Jyong Biotech Ltd trading halted, volatility trading pause
Jyong Biotech Ltd trading resumes